2 months Boston Sci Slumps After One Key Segment Drives Its Second-Quarter Beat Investor's Business Daily
Boston Scientific stock slumped Wednesday despite a “big organic revenue beat” driven by strong electrophysiology sales, one analyst said.
The post Boston Sci Slumps After One Key Segment Drives Its Second-Quarter Beat appeared first on Investor's…
Boston · Boston Scientific (BSX)